特发性膜性肾病合并急性肾损伤的危险因素分析*

蔡佳盈 ,  陈雅玲 ,  赖素仁 ,  沈世忠

四川大学学报(医学版) ›› 2026, Vol. 57 ›› Issue (4) : 1114 -1120.

PDF (2513KB)
四川大学学报(医学版) ›› 2026, Vol. 57 ›› Issue (4) : 1114 -1120. DOI: 10.12182/20260760207
论著

特发性膜性肾病合并急性肾损伤的危险因素分析*

作者信息 +

Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury

Author information +
文章历史 +
PDF (2572K)

摘要

目的 探究基于倾向性评分匹配的特发性膜性肾病合并急性肾损伤危险因素。方法 回顾性纳入2020年1月-2025年3月的310例特发性膜性肾病患者,分为急性肾损伤组(n=80)和非急性肾损伤组(n=230),从非急性肾损伤组中选择患者和急性肾损伤组患者进行PSM 1∶1匹配,获得80对数据。收集其一般资料,主要结局指标为血清肌酐、估算的肾小球滤过率(estimated glomerular filtration rate, eGFR)、血尿酸、血清P-选择素、尿肾脏损伤分子1(kidney injury molecule-1, KIM-1)水平。通过Logistic回归分析确定特发性膜性肾病合并急性肾损伤危险因素,构建特发性膜性肾病合并急性肾损伤的列线图模型。结果 匹配后,急性肾损伤组患者的5项主要结局指标与非急性肾损伤组相比,差异均有统计学意义(均P<0.05)。多因素logistic回归分析结果显示,血肌酐、eGFR、血尿酸、血清P-选择素均是特发性膜性肾病患者合并急性肾损伤的影响因素(均P<0.05)。基于上述4项影响因素构建的联合预测模型(列线图)的ROC曲线下面积(AUC)为0.945(95%CI: 0.909~0.981),校准曲线显示预测曲线与理想曲线拟合良好。Hosmer-Lemeshow检验结果支持模型校准度(χ2=7.366,P=0.498)。SHAP重要性排序显示,P-选择素是特发性膜性肾病合并急性肾损伤的重要影响因素,血尿酸、eGFR和血肌酐的重要性次之。结论 血肌酐、eGFR、血尿酸以及血清P-选择素是患者并发急性肾损伤的独立影响因素,且具有一定的预测价值。

Abstract

Objective To investigate the risk factors for idiopathic membranous nephropathy (IMN) complicated by acute kidney injury (AKI) based on propensity score matching (PSM). Methods A total of 310 IMN patients admitted between January 2020 and March 2025 were retrospectively enrolled and divided into an AKI group (n = 80) and a non-AKI group (n = 230). Patients in the non-AKI group were matched with those in the AKI group at a 1:1 ratio using PSM, resulting in 80 matched pairs. The general data of the patients were collected. The primary outcome measures included serum creatinine, estimated glomerular filtration rate (eGFR), uric acid, P-selectin, and urinary kidney injury molecule-1 (KIM-1) levels. Logistic regression analysis was performed to identify factors associated with risks for IMN complicated by AKI, and a nomogram prediction model was subsequently established. Results After PSM, all 5 primary outcome measures differed significantly between the AKI and non-AKI groups (all P < 0.05). According to multivariate logistic regression analysis, 4 outcome measures, including serum creatinine, eGFR, serum uric acid, and serum P-selectin, were all identified as factors influencing the occurrence of AKI in patients with IMN (all P < 0.05). A combined prediction model (a nomogram model) incorporating these 4 variables yielded an area under the curve (AUC) of the receiver operating characteristic curve (ROC) of 0.945 (95% CI: 0.909-0.981). The calibration curve demonstrated a good fit between the predicted and the ideal curves. Findings from the Hosmer-Lemeshow goodness-of-fit test supported adequate calibration of the model ( χ2 = 7.366, P = 0.498). Shapley additive explanations (SHAP) importance ranking analysis showed that serum P-selectin was an important influencing factor for AKI in patients with IMN, and the importance of serum uric acid, eGFR, and serum creatinine was secondary. Conclusion Serum creatinine, eGFR, blood uric acid, and serum P-selectin are independent influencing factors for patients with acute kidney injury, and they have certain predictive value.

关键词

特发性膜性肾病 / 急性肾损伤 / 倾向性评分匹配 / 危险因素

Key words

Idiopathic membranous nephropathy / Acute kidney injury / Propensity score matching / Risk factors

引用本文

引用格式 ▾
蔡佳盈,陈雅玲,赖素仁,沈世忠. 特发性膜性肾病合并急性肾损伤的危险因素分析*[J]. 四川大学学报(医学版), 2026, 57(4): 1114-1120 DOI:10.12182/20260760207

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Ronco P, Beck L, Debiec H, et al. Membranous nephropathy[J/OL]. Nat Rev Dis Primers, 2021, 7(1): 69. https://pubmed.ncbi.nlm.nih.gov/34593809/. DOI: 10.1038/s41572-021-00303-z.

[2]

中华中医药学会肾病分会, 广东省中医药学会肾病专业委员会, 杨丽虹, 等. 特发性膜性肾病中医临床实践指南(2021)[J]. 中国全科医学, 2023, 26(6): 647. DOI: 10.12114/j.issn.1007-9572.2022.0758.

[3]

China Association of Chinese Medicine Nephrology Branch, Nephrology Professional Committee of Guangdong Association of Chinese Medicine, Yang L H, et al. Clinical practice guideline for Chinese medicine in the treatment of idiopathic membranous nephropathy (2021)[J]. Chinese General Practice, 2023, 26(6): 647. DOI: 10.12114/j.issn.1007-9572.2022.0758.

[4]

薛志杰, 王荔, 杨虎, 等. 特发性膜性肾病的临床治疗进展[J]. 天津医科大学学报, 2022, 28(3): 336.

[5]

Xue Z J, Wang L, Yang H, et al. Advances in the clinical treatment of idiopathic membranous nephropathy[J]. J Tianjin Med Univ, 2022, 28(3): 336.

[6]

马嘉, 侯彦婕, 张轶欧, 等. 中成药治疗特发性膜性肾病的网状Meta分析[J]. 中国中药杂志, 2023, 48(13): 3650. DOI: 10.19540/j.cnki.cjcmm.20230418.501.

[7]

Ma J, Hou Y J, Zhang Y O, et al. Network Meta-analysis of Chinese patent medicines in treatment of idiopathic membranous nephropathy[J]. China J Chin Mat Med, 2023, 48(13): 3650. DOI: 10.19540/j.cnki.cjcmm.20230418.501.

[8]

Bharati J, Waguespack D R, Beck L H, Jr. Membranous nephropathy: updates on management[J]. Adv Kidney Dis Health, 2024, 31(4): 299. DOI: 10.1053/j.akdh.2024.04.004.

[9]

Dantas M, Silva L B B, Pontes B T M, et al. Membranous nephropathy[J]. J Bras Nefrol, 2023, 45(2): 229. DOI: 10.1590/2175-8239-JBN-2023-0046en.

[10]

高升波, 范娟, 娄兴华, 等. 并发急性肾损伤的特发性膜性肾病病人临床特征分析[J]. 青岛大学学报(医学版), 2022, 58(4): 567. DOI: 10.11712/jms.2096-5532.2022.58.106.

[11]

Gao S B, Fan J, Lou X H, et al. Clinical characteristics of patients with idiopathic membranous nephropathy with acute kidney injury[J]. J QingDao Univ (Med Sci), 2022, 58(4): 567. DOI: 10.11712/jms.2096-5532.2022.58.106.

[12]

邱妙华, 俞国庆, 庄永泽, 等. 老年膜性肾病致肾病综合征并发急性肾损伤的临床特征及预后影响因素[J]. 中国中西医结合肾病杂志, 2024, 25(11): 970. DOI: 10.3969/j.issn.1009-587X.2024.11.008.

[13]

Qiu M H, Yu G Q, Zhuang Y Z, et al. Clinical characteristics and prognostic factors of acute renal injury complicated by nephrotic syndrome in elderly patients with membranous nephropathy[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2024, 25(11): 970. DOI: 10.3969/j.issn.1009-587X.2024.11.008.

[14]

林利钊. 特发性膜性肾病合并急性肾损伤患者的临床病理特点及预后[D/OL]. 福州: 福建医科大学, 2021. https://x.cnki.net/web/xmlRead/pdf.html?pageType=pdfweb&fileName=1023485011.nh&tableName=CMFDTOTAL&dbCode=CMFD&topic=&fileSourceType=1&taskId=&from=&groupId=&appId=CRSP_BASIC_PSMC&act=&customReading=.

[15]

Lin L Z. Clinicopathological characteristics and prognosis of patients with idiopathic membranous nephropathy and acute kidney injuryAbstract[D/OL]. Fuzhou: Fujian Medical University, 2021. https://x.cnki.net/web/xmlRead/pdf.html?pageType=pdfweb&fileName=1023485011.nh&tableName=CMFDTOTAL&dbCode=CMFD&topic=&fileSourceType=1&taskId=&from=&groupId=&appId=CRSP_BASIC_PSMC&act=&customReading=.

[16]

李青, 蒋云芬, 曹娜, 等. 基于倾向性评分匹配的老年颈椎手术后亚谵妄转谵妄影响因素分析及预测模型的构建[J]. 军事护理, 2025, 42(6): 23. DOI: 10.3969/j.issn.2097-1826.2025.06.006.

[17]

Li Q, Jiang Y F, Cao N, et al. Influencing factors of subsyndromal delirium progressing to delirium after cervical spine surgery in elderly patients and the construction of prediction model based on propensity score matching[J]. Milit Nurs, 2025, 42(6): 23. DOI: 10.3969/j.issn.2097-1826.2025.06.006.

[18]

Maturo F, Rambaud S C. On the use of propensity score matching in biomedicine and pulmonology[J]. Arch Bronconeumol, 2022, 58(9): 637. DOI: 10.1016/j.arbres.2021.12.010.

[19]

Wang J, Marion-Gallois R. Propensity score matching and stratification using multiparty data without pooling[J]. Pharm Stat, 2023, 22(1): 4. DOI: 10.1002/pst.2250.

[20]

Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J/OL]. Nephron Clin Pract, 2012, 120(4): c179. https://pubmed.ncbi.nlm.nih.gov/22890468/. DOI: 10.1159/000339789.

[21]

Li Z, Weng M, Lin L, et al. Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis[J/OL]. Ren Fail, 2023, 45(1): 2194451. https://pubmed.ncbi.nlm.nih.gov/36994793/. DOI: 10.1080/0886022X.2023.2194451.

[22]

商梅芳, 程媛, 齐东丽, 等. 特发性膜性肾病患者急性肾小管损伤的相关因素分析[J]. 临床肾脏病杂志, 2024, 24(6): 452. DOI: 10.3969/j.issn.1671-2390.2024.06.003.

[23]

Shang M F, Cheng Y, Qi D L, et al. Analysis of factors associated with concurrent acute renal tubular injury in idiopathic membranous nephropathy patients[J]. Journal of Clinical Nephrology, 2024, 24(6): 452. DOI: 10.3969/j.issn.1671-2390.2024.06.003.

[24]

Li Z, Yang L, Wei L, et al. Risk factors and predictive model for renal outcomes in autoimmune membranous nephropathy with and without acute kidney injury: a retrospective cohort study[J/OL]. Peer J, 2025, 13: e19331. https://pubmed.ncbi.nlm.nih.gov/40256734/. DOI: 10.7717/peerj.19331.

[25]

Hu R, Tang S, Li C, et al. Anti-glomerular basement membrane disease superimposed on membranous nephropathy after coronavirus disease 2019: a case report[J/OL]. J Int Med Res, 2025, 53(4): 3000605251335843. https://pubmed.ncbi.nlm.nih.gov/40302662/. DOI: 10.1177/03000605251335843.

[26]

朱贺, 任奥林, 周康, 等. 老年患者全髋关节置换术后急性肾损伤的危险因素分析及预测模型建立[J]. 临床麻醉学杂志, 2021, 37(1): 50. DOI: 10.12089/jca.2021.01.011.

[27]

Zhu H, Ren L, Zhou K, et al. Risk factors analyze and establishment of predictive model of acute kidney injury in elderly patients after total hip arthroplasty[J]. J Clin Anesthesiol, 2021, 37(1): 50. DOI: 10.12089/jca.2021.01.011.

[28]

范继红, 刘江红, 王刚, 等. eGFR降低的心肌梗死患者冠状动脉介入治疗造影剂相关急性肾损伤的观察分析[J]. 中国循证心血管医学杂志, 2023, 15(5): 541. DOI: 10.3969/j.issn.1674-4055.2023.05.06.

[29]

Fan J H, Liu J H, Wang G, et al. Observation and analysis of contrast-associated acute kidney injury in myocardial infarction patients with decreased eGFR after percutaneous coronary intervention[J]. Chin J Evid Based Cardiovasc Med, 2023, 15(5): 541. DOI: 10.3969/j.issn.1674-4055.2023.05.06.

[30]

Chen T, Zhou Y, Chen X, et al. Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome[J]. Ren Fail, 2021, 43(1): 1004. DOI: 10.1080/0886022X.2021.1942913.

[31]

Nagore D, Candela A, Bürge M, et al. Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: a prospective multicenter study[J]. Rev Esp Anestesiol Reanim (Engl Ed), 2024, 71(7): 514. DOI: 10.1016/j.redare.2024.04.019.

[32]

Puti E, Rasyid H, Tandean P, et al. High uric acid level increases the risk of acute kidney injury in acute coronary syndrome patients[J]. Caspian J Intern Med, 2021, 12(3): 323. DOI: 10.22088/cjim.12.3.323.

[33]

Chen J L, Cheng T T, Huang C C, et al. Dual phenotypic characteristics of P-selectin in a mouse model of hemorrhagic shock and hepatectomy[J/OL]. Heliyon, 2023, 9(8): e18627. https://pubmed.ncbi.nlm.nih.gov/37554775/. DOI: 10.1016/j.heliyon.2023.e18627.

[34]

张静, 张宇, 许雅楠. P-选择素、肾脏损伤分子1对肾病综合征并发急性肾损伤的早期诊断价值[J]. 中国现代医学杂志, 2023, 33(9): 1. DOI: 10.3969/j.issn.1005-8982.2023.09.001.

[35]

Zhang J, Zhang Y, Xu Y N. Early diagnostic value of P-selectin and KIM-1 in nephrotic syndrome complicated with acute renal injury[J]. Chin J Mod Med, 2023, 33(9): 1. DOI: 10.3969/j.issn.1005-8982.2023.09.001.

[36]

李燕, 黄庆生, 方明星, 等. 黏附因子联合肾阻力指数对脓毒症相关性肾损伤的早期肾功能恢复的预测价值[J]. 河北医科大学学报, 2021, 24(12): 1387. DOI: 10.3969/j.issn.1007-3205.2021.12.005.

[37]

Li Y, Huang Q S, Fang M X, et al. Value of adhesion factors and renal resistance index in the prediction of early renal function recovery of patients with sepsis-associated acute kidney injury[J]. J Hebei Med Univ, 2021, 24(12): 1387. DOI: 10.3969/j.issn.1007-3205.2021.12.005.

基金资助

*福建省卫健委青年科研基金(2021QN01010226)

AI Summary AI Mindmap
PDF (2513KB)

106

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉